Mr. Robert Bloder brings a wealth of experience in all phases of pharmaceutical development, from drug concept and commercialization on both the buy and sell sides. As chief business officer, Robert concentrates on leading Ascendia's sales, marketing, and business development, as well as private placements and mergers & acquisitions (M&A). Before joining Ascendia, Robert was Vice President of Global Business Development at Apotex, one of the largest generic/specialty pharmaceutical companies in the world.